Making Gene Therapies Accessible to Patient with Ultra-Rare Conditions

Jude Samulski, a gene therapy innovator and chairman and chief scientific officer of the nonprofit Columbus Children’s Foundation, discusses how the foundation operates, the range of capabilities it is able to bring together to accelerate the development of gene therapies for children with ultra-rare disorders, and the potential to scale what it does to reach more patients in need of treatments.